**Abstract**

**Objective:** Schizotypal personality disorder (SPD) shares genetic susceptibilities and clinical features with schizophrenia. Despite growing interest for resting functional connectivity networks of schizophrenia, little is known to date about resting--connectivity networks of, and their contributions to the SPD. The current study aimed to examine the resting-state default mode network (DMN) functional connectivity in individuals with SPD.

**Method:** Twenty-five individuals with SPD and 38 normal controls underwent resting-state functional magnetic resonance imaging. We compared group differences for resing-state connectivity and then explored the links between altered connectivity and clinical symptoms in SPD subjects.

**Results:** As a result, both ROI-to-ROI and seed based analysis revealed that during resting state, the SPD group demonstrated increased connectivity from the left middle frontal gyrus to the posterior cingulate cortex compared to the normal controls. In addition, connectivity between the left parahippocampal gyrus and left middle frontal gyrus (ROIs analysis), as well as between the bilateral anterior cingulate cortex and posterior cingulate cortex (whole brain analysis), were also identified. In particular, enhanced middle frontal connectivity was negatively correlated with ideas of references and unusual perceptual experiences of SPD subjects.

**Conclusions:** The current study suggests the first neural evidence of an enhanced functional network with middle frontal regions across the resting--state network in SPD, compared to that of controls. Furthermore, these alterations may possibly take role in compensating for their clinical symptoms including thought disorder and perceptual aberrations in SPD. Our imaging evidence may provide insight on the neurocompensatory responses observed in schizophrenia spectrums.
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